A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE Study.
Saved in:
| Title: | A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE Study. |
|---|---|
| Authors: | Boakye-Dankwa E; Data Science and Advanced Analytics, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Kiddle SJ; Insight Generation, Data Science and Advanced Analytics, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK steven.kiddle@astrazeneca.com., Koo HN; Healthcare Analytics, Data Science and Advanced Analytics, BioPharmaceuticals R&D, Gothenburg, Sweden., Harper AR; Clinical Development, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ambrose CS; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Douglas IJ; Dept of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, UK., Quint JK; School of Public Health, Imperial College London, London, UK. |
| Source: | The European respiratory journal [Eur Respir J] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1399-3003 |
|---|---|
| DOI: | 10.1183/13993003.02196-2025 |
